Five-year Survival After Helicobacter pylori Eradication in Alzheimer Disease Patients
The DOI matches its Crossref record.
Abstract
BACKGROUND: Alzheimer disease (AD) is a progressive, fatal neurodegenerative condition. OBJECTIVE: We tested the hypothesis that eradication of Helicobacter pylori infection (Hp-I) could improve survival in a Greek cohort of AD patients, in a 5-year follow-up. METHOD: Forty-six patients diagnosed with probable AD were enrolled in the analysis. Study population was classified into 3 groups: patients for whom Hp eradication treatment was successful; those for whom eradication of Hp had failed, they refused, and/or were noncompliant with eradication therapy; and those who were Hp negative at baseline. Cox proportional hazards model was built with all-cause mortality as the dichotomous outcome. RESULTS: During the 5-year follow-up [47.19±15.11 mo (range 12 to 60)], overall 21 patients died and 25 patients remained alive. Patients who died were older and exhibited lower mean MMSE score compared with the patients still alive. Successful eradication of Hp-I was associated with a significantly lower mortality risk [HR (95% CI)=0.287 (0.114-0.725), P=0.008]. The results were similar in adjusted and unadjusted models, for age and MMSE at baseline. CONCLUSION: Hp eradication regimen in AD patients is associated with a higher 5-year survival rate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Malfertheiner, P., Megraud, F., Rokkas, T., Gisbert, J. P., Liou, J.-M., Schulz, C., Gasbarrini, A., Hunt, R. H., Leja, M., O'Morain, C., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327745 · Cited by 1,533
Beyond the stomach: An updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment
Testerman, T. L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.12781 · Cited by 336
Helicobacter pylori and extragastric diseases: A review
Gravina, A. G., Zagari, R. M., Musis, C. D., Romano, L., Loguercio, C., & Romano, M. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i29.3204 · Cited by 328
The Impact of Systemic Inflammation on Alzheimer’s Disease Pathology
Xie, J., Van Hoecke, L., & Vandenbroucke, R. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.796867 · Cited by 324
Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition
Kato, M., Ota, H., Okuda, M., Kikuchi, S., Satoh, K., Shimoyama, T., Suzuki, H., Handa, O., Furuta, T., Mabe, K., et al. (2019) · Helicobacter · doi:10.1111/hel.12597 · Cited by 306
Metadata
- Authors
- Kountouras, J., Boziki, M., Gavalas, E., Zavos, C., Deretzi, G., Chatzigeorgiou, S., Katsinelos, P., Grigoriadis, N., Giartza-Taxidou, E., & Venizelos, I.
- Venue
- Cognitive and Behavioral Neurology
- Published
- 2010-09
- Volume
- 23
- Issue
- 3
- Pages
- 199-204
- ISSN
- 1543-3633 (ISSN-L)
- OpenAlex
- W2323865999
- Cited by
- 110
- References
- 0
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Five-year Survival After Helicobacter pylori Eradication in Alzheimer Disease Patients. https://app.cochat.ai/papers/10.1097/wnn.0b013e3181df3034
- The paper
- Kountouras, J., Boziki, M., Gavalas, E., Zavos, C., Deretzi, G., Chatzigeorgiou, S., Katsinelos, P., Grigoriadis, N., Giartza-Taxidou, E., & Venizelos, I. (2010). Five-year Survival After Helicobacter pylori Eradication in Alzheimer Disease Patients. Cognitive and Behavioral Neurology. https://doi.org/10.1097/wnn.0b013e3181df3034
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.